Re: As Pfizer charges ahead....
|
1
|
Resverlogix Corp.
|
Sep 09, 2021 03:00PM
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
1
|
Resverlogix Corp.
|
Nov 30, 2021 01:58PM
|
Cancer research derailed by nearly two years due to COVID-19, scientists say.
|
1
|
Zenith Epigenetics
|
Apr 26, 2021 03:41PM
|
Re: Don't See Us Listed but thought it might interest some
|
1
|
Resverlogix Corp.
|
Mar 11, 2021 12:22PM
|
Merck's profit on Molnupiravir.
|
1
|
Resverlogix Corp.
|
Oct 08, 2021 01:53AM
|
Re: well according to HQ/Sarah we have been kept in loop all along....
|
1
|
Resverlogix Corp.
|
May 17, 2022 10:32AM
|
Re: Who removed my post?
|
1
|
Resverlogix Corp.
|
Nov 17, 2020 02:07PM
|
Smart or dumb move?
|
1
|
Resverlogix Corp.
|
Apr 10, 2021 08:17PM
|
Re: The Halt
|
1
|
Zenith Epigenetics
|
Aug 06, 2021 01:55AM
|
Re: Cancer research derailed by nearly two years due to COVID-19, scientists say.
|
1
|
Zenith Epigenetics
|
Apr 26, 2021 06:49PM
|
Re: Ontario long-term care home grappling with worsening COVID-19 outbreak.
|
1
|
Resverlogix Corp.
|
Jul 05, 2021 03:03PM
|
Re: So, the mood this week was.
|
1
|
Resverlogix Corp.
|
Aug 25, 2021 12:17PM
|
Re: Merck's profit on Molnupiravir.
|
1
|
Resverlogix Corp.
|
Oct 08, 2021 11:59AM
|
Re: Dream (a) reality (b)??
|
1
|
Resverlogix Corp.
|
Dec 22, 2021 12:09PM
|
AGM: This link seems to work.
|
1
|
Resverlogix Corp.
|
Jun 22, 2021 02:31PM
|
Re: Radio message, maybe Apabetalone
|
1
|
Resverlogix Corp.
|
Apr 27, 2021 03:04AM
|
An additional incentive for Pfizer?
|
1
|
Zenith Epigenetics
|
May 13, 2020 11:51PM
|
Re: Time keeps ticking
|
1
|
Resverlogix Corp.
|
Nov 18, 2021 01:16PM
|
Re: Buy Canadian !!!
|
1
|
Resverlogix Corp.
|
Jan 14, 2022 03:52PM
|
Chew on this one.
|
1
|
Resverlogix Corp.
|
Jun 20, 2020 04:18PM
|